Clinical Trial Update: Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world

View source ↗

Summary

This clinical trial update aims to assess the real-world efficacy of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia, and the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Iclusig (ponatinib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Lymphobkastic Leukemia, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | Status: NOT_YET_RECRUITING